Evidence map›Paper›PMID 31333665›Full record

ReviewFrontiers in immunology2019

Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications.

Yannick Chantran, Jean Capron, Sonia Alamowitch, Pierre Aucouturier

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yannick ChantranSorbonne Université, Inserm, UMRS 938, Hôpital St-Antoine, AP-HP, Paris, France.
Jean CapronSorbonne Université, Inserm, UMRS 938, Hôpital St-Antoine, AP-HP, Paris, France.
Sonia AlamowitchSorbonne Université, Inserm, UMRS 938, Hôpital St-Antoine, AP-HP, Paris, France.
Pierre AucouturierSorbonne Université, Inserm, UMRS 938, Hôpital St-Antoine, AP-HP, Paris, France.
Sorbonne Université · FRAssistance Publique – Hôpitaux de Paris · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral amyloid angiopathy (CAA) corresponds to the deposition of amyloid material in the cerebral vasculature, leading to structural modifications of blood vessel walls. The most frequent form of sporadic CAA involves fibrillar β-amyloid peptide (Aβ) deposits, mainly the 40 amino acid form (Aβ

Indexed as

Alzheimer DiseaseAntibodies, MonoclonalCerebral Amyloid AngiopathyImmunization, PassiveAmyloid beta-PeptidesAnimalsHumansPeptide FragmentsAmyloid beta-Peptidesamyloid beta-protein (1-40)Antibodies, MonoclonalPeptide Fragmentsanti-Aβ antibodiesautoimmunitycerebral amyloid angiopathyimmunotherapynatural antibodies

Identifiers

PMID31333665
PMCPMC6620823
OpenAlexW2953458467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.